DiPiro, Pharmacotherpy is the complete global, digital and print resource in the pharmacy market. No other competitor has near the market share (95%). In this new edition, one of the key goals is to increase our global reach. The addition of SI units will move us into this direction, along with a greater number of global examples and clinical questions.
Key Selling Features
·Full Color Text! - Online Learning Center--that features additional chapters, learning objectives, interactive questions, and more
·Delves into psychosocial issues-that affect compliance--topics related to a patient's ability to understand and manage often-complex therapy--and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes.
·Critical Presentation boxes that summarize common disease signs and symptoms
·Therapeutic recommendations in each disease-specific chapter
·Evaluation of Therapeutic Outcomes Information in each disease-specific chapter containing key monitoring guidelines
·Expanded evidence-based recommendations
·Extended coverage of the timely issue of palliative care and pain medicine
·Joe DiPiro is serving as editor of the monthly updates and this will continue for the 8/e
·Global Vision---SI Units will be included in the new edition. We should see significant increases in Canadian sales and other global markets, because of this new feature
·We have also discussed having video clips of Professors in global regions. The focus would be on how they approach and teach pharmacotherapy. Joe and Terry both have relationships with professors from overseas and will try to work with these regions to create video clips for the OLC
·Editorial has also reached out to India, Asia and the UK to seek feedback on specific features that could increase revenue through those respective regions.
·New Section Content Cardio, Pulm, Resp. *Three chapters on heart failure, instead of two. Page length will remain close to same; *PFT chapter will be moved online GI
